Funding
← Back to your selection

Alexandria Venture Investments

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
Rounds participated in
5
Confirmed lead rounds
—
5 roles undisclosed
New companies
5
First participation on record · 0 follow-on
Funding in participating rounds
$288M
5 disclosed · full round size, not this investor’s share

By stage

Series A2
Series B2
Series C+1

By primary sector

Biotech5

By country

United States5

Rounds

5 in this selection
Leal Therapeutics

Develops neuro-metabolic therapeutics for schizophrenia and ALS

$30MSeries A
Role not disclosed
Khartis Therapeutics

Develops oral small molecule therapies for immunological and chronic diseases

$50MSeries B
Role not disclosed
CREATE Medicines

Develops in vivo immune programming platform for scalable, repeat-dose immunotherapies

$122MSeries B
Role not disclosed
Alloy Therapeutics

Drug discovery platforms and integrated development services for biotechnology and pharmaceutical partners.

$40MSeries E
Role not disclosed